<- Go Home
Agfa-Gevaert NV
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services. Its Radiology Solutions segment offers analog and digital imaging technology for diagnostic imaging market to meet the needs of specialized clinicians in hospitals and imaging centers; and X-ray film, hardcopy film and printers, digital radiography equipment, and image processing software. The company’s Healthcare IT segment provides healthcare’s enterprise imaging platform. Its Digital Print & Chemicals segment offers inkjet printers for sign and display and packaging printing companies; inkjet inks and fluids for industrial inkjet applications, such as signs, posters and displays, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to the hydrogen production industry, as well as for printable synthetic papers. This segment also provides films for micrography, non-destructive testing, aerial photography and printed circuit board production; membranes for green hydrogen production; and conductive polymers and materials for the production of high-security ID documents. The company sells its products through its own sales organization, as well as through a network of agents and representatives. Agfa-Gevaert NV was founded in 1867 and is headquartered in Mortsel, Belgium.
Market Cap
EUR 182.7M
Volume
210.7K
Cash and Equivalents
EUR 54.0M
EBITDA
EUR 9.0M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
EUR 347.0M
Profit Margin
30.71%
52 Week High
EUR 2.51
52 Week Low
EUR 0.98
Dividend
N/A
Price / Book Value
0.47
Price / Earnings
-3.78
Price / Tangible Book Value
1.26
Enterprise Value
EUR 232.7M
Enterprise Value / EBITDA
8.95
Operating Income
-EUR 15.0M
Return on Equity
11.14%
Return on Assets
-0.61
Cash and Short Term Investments
EUR 54.0M
Debt
EUR 102.0M
Equity
EUR 382.0M
Revenue
EUR 1.1B
Unlevered FCF
EUR 43.5M
Sector
Health Care Technology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium